FundedIQ
Food and Beverage

Millow.co

Millow. co Producer of mycelium-based food items that aim to provide nutritious non-meat alternatives .

millow.co Västra Frölunda, Sweden 1-10 employees
Total raised
$2.3M
Rounds
1
Latest
Series Unknown
Aug 2026

Millow. co Producer of mycelium-based food items that aim to provide nutritious non-meat alternatives .

Millow.co has raised $2.3M across 1 round. Its most recent round was a Series Unknown of $2.3M in Aug 2026. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with FundedIQ

1 round on record.

Date
Round
Amount
Lead investor
Aug 13, 2026
Series Unknown
$2.3M

Unlock the lead investor and full details for this round.

Start 14-day free trial →

People

Unlock with FundedIQ

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.

Start 14-day free trial →

Millow.co is featured in

Similar companies

Quartr

Quartr is a finance-focused software company that offers a range of services through its product suite, including a free mobile app and a web app designed for professionals. The main goal of these tools is to connect the financial community. With over 500,000 users worldwide, including private investors, journalists, and corporate professionals, Quartr has become a leading source of first-party company information online. The Quartr mobile app is free to download on both iOS and Android platforms, providing access to information on over 6500 public companies in 19 markets. Users can find details on earnings calls, investor presentations, searchable transcripts with smooth text-to-audio transitions, earnings reports, and specific financial data.

Series Unknown $18.0M
Aloi

Aloi is a software development platform.

Seed $7.0M
Lovable

Best source of info -> lovable.dev We are a small team of serial founders, product engineers, physicists, competitive programmers and people who just care about building a great product and shipping fast. We have quickly built a product that users are raving about: gptengineer.app We have our roots in open source code generation, and believe that rapid experimentation and hiring the brightest and most ambitious minds is the only way to achieve our ambitious mission.

Series C $400M
ImagiLabs

imagiLabs builds gadgets that are customisable through coding from a mobile app, and a community for teenage girls to share their interest in coding.

Seed $4.5M
Neko Health

Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the maintenance of good health through preventive measures and early detection. Their innovative medical scanning technology concept enables the convenient and cost-effective collection of comprehensive health data, without the need for invasive procedures, making it accessible to the general public.

Series C $700M
Float

Float offers revenue-based financing specifically for B2B SaaS companies.

Series A $5.2M
Caplyzer

Caplyzer develops and patented a new solution for water electrolysis.

Seed $730k
Original Creation

Original Creation creates the digital product passport and supply chain transparency of the future.

Seed $800k
Tendavo

Tendavo is an AI-driven service that helps small and mid-sized companies win public procurement contracts by handling the tender process.

Seed $1.0M
Blaise

Blaise is developing a software platform driven by AI that will allow businesses to develop unique commercial apps.

Seed $500k
MiMove

MiMove is a different kind of property portal. We are a regulated marketplace. That means that we visit and vet all real estate agencies before they can post their properties on MiMove – and exclude agencies who do not follow our rules. That is why we dare say that we are the safest marketplace for properties abroad.

Series Unknown $510k
Oblique Therapeutics

Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.

Series Unknown $1.4M
14-day free trial · Cancel anytime

Know who just raised. Then know who to call.

Every newly funded startup with its round, its investors, and its founders — delivered weekly, or searchable back to 2020.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.